Howard Liang, CFO & Chief Strategy Officer at BeiGene, Ltd. (BGNE), sold 27,700 shares at $344.28 ($9.6M) on 2021-01-14, disclosed to the SEC on 2021-01-19.
Open-market sale of $9.6M BGNE by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $344.28 | 1,100 | $379K | 4.0% |
| 2 | $344.28 | 1,100 | $379K | 4.0% |
| 3 | $345.15 | 300 | $104K | 1.1% |
| 4 | $344.38 | 6,994 | $2.4M | 25.2% |
| 5 | $344.38 | 6,994 | $2.4M | 25.2% |
| 6 | $345.54 | 5,606 |
| $1.9M |
| 20.3% |
| 7 | $345.54 | 5,606 | $1.9M | 20.3% |
| Total | $344.85 avg | 27,700 | $9.6M | 100% |
| Filing → |
| BGNE | SELL | 2021-06-09 | $460K | — | Filing → |
| BGNE | SELL | 2020-12-16 | $39.2M | — | Filing → |
| BGNE | SELL | 2020-10-07 | $7.5M | — | Filing → |